ISLAMABAD: China needs stronger oversight, better data transparency and more specialised talent as artificial intelligence (AI) moves further into healthcare, national political adviser Wang Jian\u2019an said, while adding that international cooperation, including with the United States, remains important in medical AI. Speaking to reporters on the sidelines of China\u2019s annual Two Sessions meetings, Wang, a member of the Chinese People\u2019s Political Consultative Conference National Committee and president of the Second Affiliated Hospital of Zhejiang University School of Medicine, said his proposals this year focus on two areas: advancing brain-computer interface technology from research into hospital use, and addressing the ethical and safety risks of AI in healthcare, according to China Economic Net (CEN) on Sunday. Asked about the biggest bottlenecks facing medical AI in clinical use, he said one concern was the quality and safety of data, and that other problems include limited model transparency and weak post-deployment oversight. DNA
\nOn international cooperation, he said China and the United States are both competitors and partners in medical AI, but added that cooperation could outweigh competition.
\nHe said different countries had different strengths. Some Western countries have advantages in chips and materials, while China has moved faster in some open-source areas and has strengths in disease diversity and clinical application scenarios.
\nIn areas such as disease screening, imaging assistance and chronic disease management, he said international collaboration could help combine knowledge, population data and biological information from different groups, giving researchers a fuller basis to answer scientific questions.
\nAsked about China\u2019s advantages over international peers, he cited policy support, broader public uptake of AI, growing experience in clinical applications and stronger integration between medicine and engineering.
\nHe also said China\u2019s large patient volumes and broad range of disease cases provide hospitals with extensive clinical data to support research and development.
\nHe said the growing use of Chinese medical AI solutions in developing countries reflects China\u2019s technological progress, adding that such collaboration gives developing countries access to advances they would otherwise struggle to afford.<\/p>\n","protected":false},"excerpt":{"rendered":"
ISLAMABAD: China needs stronger oversight, better data transparency and more specialised talent as artificial intelligence (AI) moves further into healthcare, national political adviser Wang Jian\u2019an said, while adding that international cooperation, including with the United States, remains important in medical AI. Speaking to reporters on the sidelines of China\u2019s annual Two Sessions meetings, Wang, a […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":{"0":"post-535612","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-national"},"yoast_head":"\n